Novartis hears pitches to consolidate its agency roster

Share this article:
Novartis has heard pitches for its consumer and professional advertising business with a view toward consolidating its agency roster into 2-4 integrated shops.
The company's global advertising head, Kurt Graves, told Advertising Age that Novartis was torn between seeking global bulk and creative brawn in both consumer and professional. "Nobody has both," Graves told Advertising Age, adding that he had ruled out consolidating Novartis' advertising business into one holding company, as Sanofi-Synthelabo did recently with Publicis Groupe.
Included in the pitch were Deutsch, which handles Lamisil and Zelnorm DTC, Merkley & Partners, which handles Elidel DTC, and Commonhealth Group's Noesis, which handles Elidel and Lotrel professional, as well as non-roster shops such as InChord's GSW Worldwide, DDB Worldwide, Saatchi & Saatchi. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.